Bionano Genomics (NASDAQ:BNGO) initiated with an Outperform rating and a $1.50 (443% upside) price target at Oppenheimer. Shares up 19% premarket.
NovoCure (NASDAQ:NVCR) initiated with an Overweight rating and a $85 (32% upside) price target at Piper Sandler.
Regeneron Pharmaceuticals (NASDAQ:REGN) initiated with a Hold rating at Benchmark.
Varian Medical Systems (NYSE:VAR) initiated with an Overweight rating and a $126 (18% upside) price target at Piper Sandler.
DENTSPLY SIRONA (NASDAQ:XRAY) upgraded to Outperform with a $49 (29% upside) price target at Baird. Shares up 1% premarket.
Molina Healthcare (NYSE:MOH) upgraded to Buy with a $171 (22% upside) price target at Bank of America.
NuVasive (NASDAQ:NUVA) upgraded to Outperform with a $66 (31% upside) price target at Baird.
Omega Healthcare Investors (NYSE:OHI) upgraded to Sector Outperform at Scotiabank.
Sage Therapeutics (NASDAQ:SAGE) downgraded to Neutral at Guggenheim. Shares down 1% premarket after its announced job cuts.
https://seekingalpha.com/news/3559236-bofa-likes-molina-healthcare-in-premarket-analyst-action
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.